您的当前位置:首页 > 行业数据 > 图表31国内靶向KRAS-G12C二线NSCLC治疗竞争格局及临床数据对比(非头对头)
图片属性
图片格式:PNG 图片大小:344KB 图片尺寸:2302*990
同报告图片
 / 4
图表31国内靶向KRAS-G12C二线NSCLC治疗竞争格局及临床数据对比(非头对头)_第1页
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
图表31国内靶向KRAS-G12C二线NSCLC治疗竞争格局及临床数据对比(非头对头)_第2页
图表31国内靶向KRAS-G12C二线NSCLC治疗竞争格局及临床数据对比(非头对头)_第3页
图表31国内靶向KRAS-G12C二线NSCLC治疗竞争格局及临床数据对比(非头对头)_第4页
图表31国内靶向KRAS-G12C二线NSCLC治疗竞争格局及临床数据对比(非头对头)_第5页
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
所属报告: 中国生物制药-港股公司研究报告:百亿单品可期四大板块并进创新+国际化双轮驱动-241008(31页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠